This was also evident by a mouse model that showed biallelic C\ebpα led to myeloid leukemia development, and the addition of Gata2 mutation to the latter promoted leukemia progression, with 40% of triple transgenic mice developing leukemia with both erythroid and myeloid features. This evidence concerns the gene GATA2 and leukemia.